The stock market isn't in the best shape; nor is the global economy. Inflation, supply chain issues, and geopolitical tensions are all contributing to the troubles on Wall Street and Main Street. For those looking for companies that can survive any recession, it might be worth considering corporations that have done it plenty of times before.
Sanofi (SNY) pauses enrollment in late-stage studies evaluating its BTK inhibitor in multiple sclerosis and myasthenia gravis after the FDA places a partial clinical hold on these studies.
Investors are optimistic about STERIS (STE) owing to its robust segmental results and the ongoing Cantel Medical integration.